How to Read a Peptide Certificate of Analysis (COA): HPLC, Mass Spectrometry & Batch Verification

A peptide Certificate of Analysis, or COA, is most useful when it connects a specific sample with the laboratory that tested it, the analytical methods used, the reported results, and identifiers that allow the documentation to be traced.

A purity percentage alone does not provide the full analytical picture. HPLC, mass spectrometry, peptide-content testing, and batch information answer different questions. Reading them together helps you understand what the report actually shows and whether it corresponds to the material being evaluated.

The most useful way to review a COA is to follow a clear verification path:

Product or vial → lot number → laboratory report → accession or report ID → analytical results

This guide explains how to follow that path and what each part of a peptide COA means.

What Is a Peptide Certificate of Analysis?

A Certificate of Analysis reports analytical results for a tested sample or production batch.

The exact format depends on the laboratory and the scope of testing. A peptide COA may include chromatographic purity, molecular-mass data, measured peptide content, testing dates, sample identifiers, and laboratory information.

These measurements should not be treated as interchangeable.

Peptide quality assessment can involve separate evaluations of:

• identity
• chromatographic purity
• impurities
• peptide quantity
• sample traceability

Research published by scientists from the United States Pharmacopeial Convention describes these as distinct analytical considerations that may require complementary methods.

A COA is therefore more than a headline purity number. Its value comes from showing what was tested, how it was tested, and which sample the results relate to.

What Should You Check on a Peptide COA?

A practical review should start with identification and traceability before focusing on the highest number on the report.

Compound or Sample Identification

Confirm that the report identifies the peptide being evaluated.

Some laboratories may also use an internal sample code or accession identifier. The report should provide enough information to connect the submitted sample with the analytical results.

Batch or Lot Number

The batch or lot number helps connect the COA with a specific production lot.

Check whether the number shown on the laboratory report matches the product listing or vial being reviewed.

Testing Laboratory

Identify the laboratory responsible for the analysis.

A named laboratory provides a clear source for the reported results and may offer a public method for checking laboratory records.

The fact that a laboratory is identified does not, by itself, establish every aspect of analytical quality. It does make the source of the testing more transparent.

Report or Accession Number

Many laboratories assign a unique accession, report, or submission number.

This identifier is particularly useful when the laboratory offers an online verification system because it allows the published COA to be compared with the underlying laboratory record.

Analytical Methods

Review the methods used to generate the reported results.

Common techniques in peptide analysis include HPLC and mass spectrometry. Some reports may also include a separate quantitative peptide-content measurement.

The method matters because different analytical procedures answer different questions.

How to Read HPLC Purity on a Peptide COA

High-performance liquid chromatography, or HPLC, separates components in a prepared sample.

As those components move through the chromatographic system, a detector records signals that appear as peaks on a chromatogram.

Common terms include:

• Retention time: when a component reaches the detector
• Main peak: the dominant chromatographic response
• Minor peaks: additional detected components
• Peak area: the integrated detector response
• Area percentage: a peak’s relative contribution to the measured chromatographic area

A result such as 99% HPLC purity generally means that the main integrated peak represents about 99% of the relevant chromatographic area under the conditions of that test.

It does not automatically mean that the target peptide accounts for 99% of the total physical mass in the vial.

The result depends on the analytical method, detector, sample preparation, chromatographic conditions, and peak integration. This is why HPLC purity should be interpreted as an analytical result rather than a standalone guarantee of overall product composition.

What Does Mass Spectrometry Show on a Peptide COA?

Mass spectrometry provides information that differs from HPLC.

The technique measures ions according to their mass-to-charge ratio. The resulting data can show whether the measured molecular species is consistent with the expected peptide.

In practical terms:

COA Element	Main Question It Helps Answer
HPLC	What does the chromatographic purity profile look like?
Chromatogram	What peaks were detected and how large are they?
Mass spectrometry	Is the measured molecular species consistent with the expected compound?
Net peptide content	How much peptide was measured?
Lot number	Which batch does the report relate to?
Accession or report ID	Can the laboratory record be traced or checked?

HPLC and mass spectrometry complement one another. HPLC primarily evaluates separation and chromatographic purity, while mass spectrometry provides molecular-mass information that can support identity.

Neither technique should be described as answering every analytical question on its own.

Peptide Purity vs Net Peptide Content

HPLC purity and net peptide content are separate measurements.

A result such as 99.7% purity describes the chromatographic profile under the analytical method. A result such as 12.8 mg net peptide content describes the measured quantity of peptide in the tested sample.

One value should not be used as a substitute for the other.

For a deeper explanation of how quantitative peptide content differs from chromatographic purity and nominal vial labeling, see our guide to net peptide content in research peptides.

For a compound-specific example, our guide to Semaglutide purity, HPLC testing, and COA interpretation explains how those measurements appear together in a real analytical record.

How to Verify a Peptide COA

Start with the product or vial and identify the listed lot number.

Next, compare that identifier with the laboratory report. The compound and batch information should correspond.

Then identify the testing laboratory and locate any report, accession, or search code associated with the sample.

If the laboratory provides a public verification system, use that identifier to check the underlying record.

Finally, compare the analytical results listed by the supplier with the laboratory record. Relevant fields may include:

• compound name
• lot or sample identifier
• purity result
• testing method
• peptide content
• report date
• accession number

The goal is not simply to find a document labeled “COA.” The goal is to establish a logical connection between the tested sample, the laboratory record, and the batch being reviewed.

Example: Following a Peptide Batch From Product Page to COA

The following example shows how the verification process works. It does not mean every laboratory uses the same fields, format, or reporting system.

At the time this article was reviewed, the Profound Peptides Semaglutide RUO 10mg product page listed:

Field	Reported Information
Product	Semaglutide RUO 10mg
Lot number	SM10-2252026
HPLC purity	99.712%
Net peptide content	12.86 mg
Testing method	HPLC with UV Detection + Mass Spectrometry
Testing laboratory	Freedom Diagnostics
COA accession	2603130113
Search code	Prof2603130113

The verification process starts by matching the product with lot SM10-2252026.

The next step is checking the laboratory information and accession number. The published accession, 2603130113, provides a specific identifier for the laboratory report.

The analytical results can then be read separately:

• 99.712% describes the reported chromatographic purity
• 12.86 mg describes the reported net peptide content
• mass spectrometry provides molecular information that supports identity
• the lot and accession identifiers connect the analytical record with the listed batch

This gives more context than a general statement such as “99%+ purity” without supporting batch information.

Because product lots can change, researchers should review the current Semaglutide batch specifications rather than assuming that analytical results from an earlier batch apply to a later one.

What Makes a Peptide COA Harder to Verify?

Certain omissions do not prove that a COA is invalid, but they reduce the amount of information available for independent evaluation.

Look more closely when a report or product listing has:

• no identifiable batch or lot number
• no named testing laboratory
• a purity percentage without a stated analytical method
• different lot numbers between the product listing and laboratory report
• no report or accession identifier when independent verification is claimed
• purity presented as though it also represents peptide quantity
• documentation from an older batch being used for a newer lot without explanation

A professional-looking document is not the same as a traceable analytical record.

The stronger question is:

Can the reported results be followed from the laboratory record back to the specific batch being evaluated?

If that connection is clear, the COA provides substantially more useful information.

Frequently Asked Questions About Peptide COAs